In situ growth of a C-terminal interferon-alpha conjugate of a phospholipid polymer that outperforms PEGASYS in cancer therapy.

MLA

Hu, Jin, et al. “In Situ Growth of a C-Terminal Interferon-Alpha Conjugate of a Phospholipid Polymer That Outperforms PEGASYS in Cancer Therapy.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 237, Sept. 2016, pp. 71–77. EBSCOhost, https://doi.org/10.1016/j.jconrel.2016.07.007.

APA

Hu, J., Wang, G., Zhao, W., & Gao, W. (2016). In situ growth of a C-terminal interferon-alpha conjugate of a phospholipid polymer that outperforms PEGASYS in cancer therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society, 237, 71–77. https://doi.org/10.1016/j.jconrel.2016.07.007

Chicago

Hu, Jin, Guilin Wang, Wenguo Zhao, and Weiping Gao. 2016. “In Situ Growth of a C-Terminal Interferon-Alpha Conjugate of a Phospholipid Polymer That Outperforms PEGASYS in Cancer Therapy.” Journal of Controlled Release : Official Journal of the Controlled Release Society 237 (September): 71–77. doi:10.1016/j.jconrel.2016.07.007.